Argent Capital Management Lowered Biogen (BIIB) Stake by $13.09 Million; Bridgewater …

Bridgewater Associates Lp decreased its stake in Open Text Corp (OTEX) by 13.78% based on its latest 2018Q4 regulatory filing with the SEC.

Open Text Corporation (NASDAQ:OTEX) Logo

Argent Capital Management Llc decreased its stake in Biogen Inc. (BIIB) by 33.36% based on its latest 2018Q4 regulatory filing with the SEC. Argent Capital Management Llc sold 43,636 shares as the company’s stock declined 1.50% while stock markets rallied. The institutional investor held 87,154 shares of the biological products (no diagnostic substances) company at the end of 2018Q4, valued at $26.23M, down from 130,790 at the end of the previous reported quarter. Argent Capital Management Llc who had been investing in Biogen Inc. for a number of months, seems to be less bullish one the $44.19 billion market cap company. The stock decreased 3.46% or $8.16 during the last trading session, reaching $227.91. About 1.69 million shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 15.91% since May 7, 2018 and is uptrending. It has outperformed by 11.54% the S&P500. Some Historical BIIB News: 24/04/2018 – Biogen Idec 1Q Adj EPS $6.05; 07/03/2018 – EMA- EMA RECOMMENDS IMMEDIATE SUSPENSION AND RECALL OF MULTIPLE SCLEROSIS MEDICINE ZINBRYTA; 25/04/2018 – BIOGEN INC BIIB.O : BAIRD RAISES TO OUTPERFORM; 24/04/2018 – BIOGEN 1Q TECFIDERA REV. $986.9M, EST. $1.01B; 06/03/2018 – PROMIS NEUROSCIENCES INC – PMN310 SHOWED SIMILAR ABILITY TO CROSS BLOOD BRAIN BARRIER AND PENETRATE CENTRAL NERVOUS SYSTEM COMPARED TO ADUCANUMAB; 23/04/2018 – BIOGEN: NEW SPINRAZA DATA UNVEILED AT AAN ANNUAL MEETING SHOW; 17/05/2018 – BIOGEN TO EXERCISE CALL OPTIONS ON SAMSUNG BIOEPIS BY JUNE 29; 24/04/2018 – Biogen’s rain-making rare-disease drug hits a sales slump; 07/05/2018 – Eaton Vance Worldwide Health Adds Glaxo, Cuts Biogen; 01/05/2018 – Biogen Will Pay $50 Million To Reduce Royalties On Alzheimer’s Disease Drug — MarketWatch

Bridgewater Associates Lp decreased its stake in Open Text Corp (OTEX) by 13.78% based on its latest 2018Q4 regulatory filing with the SEC. Bridgewater Associates Lp sold 13,350 shares as the company’s stock rose 9.45% with the market. The hedge fund held 83,536 shares of the edp services company at the end of 2018Q4, valued at $2.72M, down from 96,886 at the end of the previous reported quarter. Bridgewater Associates Lp who had been investing in Open Text Corp for a number of months, seems to be less bullish one the $10.61 billion market cap company. The stock decreased 1.77% or $0.71 during the last trading session, reaching $39.49. About 211,788 shares traded. Open Text Corporation (NASDAQ:OTEX) has risen 9.17% since May 7, 2018 and is uptrending. It has outperformed by 4.80% the S&P500. Some Historical OTEX News: 02/04/2018 MADHU RANGANATHAN JOINS OPENTEXT AS CHIEF FINANCIAL OFFICER; 10/05/2018 – OPEN TEXT CORP OTEX.TO : BARCLAYS RAISES TARGET PRICE TO C$59 FROM C$57; 30/05/2018 – OPEN TEXT -AMENDMENT OF TERM LOAN INCREASES AMOUNT TO US$1 BLN, EXTENDS MATURITY DATE TO 2025, REDUCES INTEREST RATE MARGIN BY 25 BASIS POINTS; 17/04/2018 – Open Text Closes Above 50-Day Moving Average: Technicals; 18/05/2018 – Document Management Software 2018: Global Procurement Market Intelligence Report – Top Five Players are Adobe, OpenText, Dropbox, HP, and Oracle – ResearchAndMarkets.com; 17/04/2018 – BLUE HARBOUR GROUP LP CEO CLIFF ROBBINS TELLS 13D MONITOR CONFERENCE THAT THERE IS “POTENTIAL FOR A STRATEGIC SALE DOWN THE ROAD” FOR OPEN TEXT CORP OTEX.TO , IN WHICH BLUE HARBOUR OWNS 4 PCT STAKE; 09/05/2018 – Open Text 3Q Net $58.8M; 30/05/2018 – OPENTEXT ANNOUNCES REPRICING AND AMENDMENT OF CREDIT FACILITIES; 15/05/2018 – OpenText to Bring Security to the Edges of the Network and Beyond; 30/05/2018 – OPENTEXT TERM LOAN INCREASED TO $1B, MATURITY DATE TO 2025

Analysts await Open Text Corporation (NASDAQ:OTEX) to report earnings on May, 8. They expect $0.08 earnings per share, down 63.64% or $0.14 from last year’s $0.22 per share. OTEX’s profit will be $21.49M for 123.41 P/E if the $0.08 EPS becomes a reality. After $0.39 actual earnings per share reported by Open Text Corporation for the previous quarter, Wall Street now forecasts -79.49% negative EPS growth.

Bridgewater Associates Lp, which manages about $10.93 billion US Long portfolio, upped its stake in Block H & R Inc (NYSE:HRB) by 22,445 shares to 33,567 shares, valued at $852,000 in 2018Q4, according to the filing. It also increased its holding in Las Vegas Sands Corp (NYSE:LVS) by 91,866 shares in the quarter, for a total of 119,032 shares, and has risen its stake in Ford Mtr Co Del (NYSE:F).

More notable recent Open Text Corporation (NASDAQ:OTEX) news were published by: Seekingalpha.com which released: “Open Text Acquires Catalyst Repository Systems For eDiscovery Tech – Seeking Alpha” on February 06, 2019, also Seekingalpha.com with their article: “Open Text Corporation (OTEX) CEO Mark Barrenechea on Q2 2019 Results – Earnings Call Transcript – Seeking Alpha” published on January 31, 2019, Fool.com published: “OpenText Looks to Acquisitions for Growth – Motley Fool” on February 01, 2019. More interesting news about Open Text Corporation (NASDAQ:OTEX) were released by: Nasdaq.com and their article: “After-Hours Earnings Report for January 31, 2019 : AMZN, AFL, EW, MCK, YUMC, AJG, SYMC, EMN, PKI, OTEX, CPT, FBHS – Nasdaq” published on January 31, 2019 as well as Prnewswire.com‘s news article titled: “OpenText Releases New Cloud and Hybrid Offerings for SAP® Solutions – PRNewswire” with publication date: May 03, 2019.

Since January 30, 2019, it had 2 buys, and 0 insider sales for $47.78 million activity.

Investors sentiment decreased to 0.91 in Q4 2018. Its down 0.10, from 1.01 in 2018Q3. It worsened, as 79 investors sold BIIB shares while 314 reduced holdings. 83 funds opened positions while 276 raised stakes. 181.17 million shares or 8.34% more from 167.21 million shares in 2018Q3 were reported. Ingalls And Snyder Limited Co, a New York-based fund reported 7,437 shares. Country Tru Financial Bank reported 112,718 shares or 1.69% of all its holdings. 3,074 were accumulated by Walleye Trading Limited Liability. 2,118 are owned by Heritage Wealth Advsr. Toronto Dominion Savings Bank reported 0.06% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Covington Capital has invested 0% of its portfolio in Biogen Inc. (NASDAQ:BIIB). D E Shaw And accumulated 397,153 shares. Teachers Retirement Sys Of The State Of Kentucky has invested 0.44% in Biogen Inc. (NASDAQ:BIIB). Bamco Ny reported 0.02% in Biogen Inc. (NASDAQ:BIIB). Stevens Cap Mgmt Ltd Partnership invested 0.02% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Nordea Investment Ab owns 425,614 shares. 3,891 are owned by Buckingham Capital Mngmt. Parnassus Invests Ca has invested 0.46% in Biogen Inc. (NASDAQ:BIIB). Cibc World Mkts Corporation has invested 0.19% in Biogen Inc. (NASDAQ:BIIB). Moreover, Culbertson A N Co Inc has 0.08% invested in Biogen Inc. (NASDAQ:BIIB).

Biogen Inc. (NASDAQ:BIIB) Ratings Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

Rowland & Company Investment Counsel Has Upped Microsoft (MSFT) Position By $172.97 …

… 3Q Rev $26.8B; 04/04/2018 – ECS Achieves AWS Microsoft Workloads Competency Status; 21/05/2018 – Microsoft has bought Semantic Machines, …

Biogen Inc. (NASDAQ:BIIB) Logo

Rowland & Company Investment Counsel increased Microsoft Corp (MSFT) stake by 2.63% reported in 2018Q4 SEC filing. Rowland & Company Investment Counsel acquired 1,703 shares as Microsoft Corp (MSFT)’s stock rose 1.03%. The Rowland & Company Investment Counsel holds 66,376 shares with $6.74 billion value, up from 64,673 last quarter. Microsoft Corp now has $968.54 billion valuation. The stock decreased 1.16% or $1.49 during the last trading session, reaching $126.39. About 16.06M shares traded. Microsoft Corporation (NASDAQ:MSFT) has risen 20.90% since May 2, 2018 and is uptrending. It has outperformed by 16.53% the S&P500. Some Historical MSFT News: 13/03/2018 – CafeX Extends CRMs Power with New Release of Live Assist for Microsoft Dynamics 365; 02/05/2018 – Oath also uses certain cloud services from Google and Microsoft; 26/04/2018 – MICROSOFT – QTRLY DILUTED EARNINGS PER SHARE WAS $0.95 AND INCREASED 36%; 27/04/2018 – The “Mad Money” host says Microsoft and Intel could rule the world again; 30/04/2018 – Partnership with Microsoft will bring computer science to four El Paso schools; 26/04/2018 – Microsoft 3Q Rev $26.8B; 04/04/2018 – ECS Achieves AWS Microsoft Workloads Competency Status; 21/05/2018 – Microsoft has bought Semantic Machines, an artificial intelligence start-up that adds context to conversations and improves speech recognition with chatbots; 30/04/2018 – VMWARE: MICROSOFT AZURE NEXT PARTNER FOR VMW’S NETWORKING CLOUD; 15/05/2018 – Bluecrest Adds Lockheed, Exits Altria, Cuts Microsoft: 13F

Willingdon Wealth Management increased Biogen Inc (BIIB) stake by 2923.08% reported in 2018Q4 SEC filing. Willingdon Wealth Management acquired 3,800 shares as Biogen Inc (BIIB)’s stock declined 1.50%. The Willingdon Wealth Management holds 3,930 shares with $1.18 million value, up from 130 last quarter. Biogen Inc now has $44.77B valuation. The stock increased 0.61% or $1.41 during the last trading session, reaching $230.91. About 1.05 million shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 15.91% since May 2, 2018 and is uptrending. It has outperformed by 11.54% the S&P500. Some Historical BIIB News: 23/04/2018 – Biogen: Later-Onset Spinal Muscular Atrophy Patients Treated With Spinraza Walked Longer Distances While Experiencing Stable or Less Fatigue Over Time; 05/04/2018 – Biogen To Launch Imraldi in Europe on October 16; 20/04/2018 – DJ Biogen Inc, Inst Holders, 1Q 2018 (BIIB); 11/04/2018 – moneycontrol: In exclusive pact, Eisai to distribute Biogen’s multiple-sclerosis portfolio in India; 27/04/2018 – Biogen Closes Above 50-Day Moving Average: Technicals; 23/04/2018 – Biogen’s Tecfidera Falls After 1-Wk Rise, Avonex Declines: MS; 11/04/2018 – STAT Plus: Biogen and the badly needed gene therapy acquisition that got away; 01/05/2018 – BIIB TO MAKE 1-TIME $50M PAYMENT TO NEURIMMUNE FOR 5% REDUCTION; 30/05/2018 – STAT Plus: Pharmalittle: Biogen escapes a compulsory license; could Ambien cause racist tweeting?; 14/03/2018 – Rydex Biotechnology Cuts Biogen

Since November 5, 2018, it had 0 insider purchases, and 6 sales for $34.60 million activity. Nadella Satya had sold 267,466 shares worth $28.35 million on Wednesday, February 6. Capossela Christopher C also sold $422,000 worth of Microsoft Corporation (NASDAQ:MSFT) shares. Shares for $214,363 were sold by BROD FRANK H. $4.06 million worth of Microsoft Corporation (NASDAQ:MSFT) shares were sold by Hogan Kathleen T.

Investors sentiment increased to 0.94 in Q4 2018. Its up 0.13, from 0.81 in 2018Q3. It is positive, as 55 investors sold MSFT shares while 925 reduced holdings. 168 funds opened positions while 758 raised stakes. 5.48 billion shares or 3.82% more from 5.28 billion shares in 2018Q3 were reported. Jag Cap Mngmt Ltd Llc holds 3.22% of its portfolio in Microsoft Corporation (NASDAQ:MSFT) for 172,071 shares. Jcic Asset Mgmt Inc holds 1.74% in Microsoft Corporation (NASDAQ:MSFT) or 38,696 shares. Advisory Ser reported 0.49% of its portfolio in Microsoft Corporation (NASDAQ:MSFT). 34,449 are owned by Sol Cap Management Com. Chilton Management Limited Liability Corp reported 272,895 shares. Boys Arnold & Co Incorporated has 56,652 shares. Edge Wealth Management Llc holds 145,069 shares or 4.15% of its portfolio. Somerset Tru holds 83,950 shares or 4.96% of its portfolio. Jpmorgan Chase Communications invested in 88.59M shares or 2.08% of the stock. Janney Limited Liability Company stated it has 2.12% in Microsoft Corporation (NASDAQ:MSFT). Natixis has invested 2.87% in Microsoft Corporation (NASDAQ:MSFT). Appleton Prtnrs Ma invested in 106,962 shares. 496,202 are held by Oakmont Corporation. Moreover, Hemenway Com Ltd Limited Liability Company has 2.69% invested in Microsoft Corporation (NASDAQ:MSFT). 5.84M were accumulated by Proshare Advsr Ltd Liability.

More notable recent Microsoft Corporation (NASDAQ:MSFT) news were published by: Seekingalpha.com which released: “Microsoft: Suprisingly Steady Growth – Seeking Alpha” on May 02, 2019, also Seekingalpha.com with their article: “Microsoft’s Strong Results May Push Shares Even Higher – Seeking Alpha” published on May 01, 2019, Nasdaq.com published: “Microsoft (MSFT) 3rd Quarter Earnings: What to Expect – Nasdaq” on April 24, 2019. More interesting news about Microsoft Corporation (NASDAQ:MSFT) were released by: Nasdaq.com and their article: “Factors to Consider Ahead of Microsoft’s (MSFT) Q3 Earnings – Nasdaq” published on April 22, 2019 as well as Nasdaq.com‘s news article titled: “Technology Sector Update for 05/02/2019: ZNGA, CDAY, SQ, MSFT, AAPL, IBM, CSCO, GOOG – Nasdaq” with publication date: May 02, 2019.

Among 12 analysts covering Microsoft (NASDAQ:MSFT), 12 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Microsoft had 19 analyst reports since November 26, 2018 according to SRatingsIntel. The stock has “Buy” rating by UBS on Thursday, April 25. The rating was maintained by Morgan Stanley with “Overweight” on Thursday, April 25. The stock has “Overweight” rating by Barclays Capital on Thursday, April 25. The stock of Microsoft Corporation (NASDAQ:MSFT) earned “Overweight” rating by Barclays Capital on Friday, April 12. On Thursday, November 29 the stock rating was maintained by Wedbush with “Buy”. The rating was maintained by Deutsche Bank on Monday, November 26 with “Buy”. RBC Capital Markets maintained it with “Buy” rating and $130 target in Monday, March 25 report. Nomura maintained Microsoft Corporation (NASDAQ:MSFT) on Thursday, April 25 with “Buy” rating. The rating was maintained by KeyBanc Capital Markets on Thursday, April 25 with “Overweight”. The stock of Microsoft Corporation (NASDAQ:MSFT) has “Overweight” rating given on Wednesday, April 17 by KeyBanc Capital Markets.

Rowland & Company Investment Counsel decreased Lilly Eli & Co (NYSE:LLY) stake by 215 shares to 39,033 valued at $4.52B in 2018Q4. It also reduced Clorox Company (NYSE:CLX) stake by 811 shares and now owns 2,378 shares. Weyerhaeuser Co Reit (NYSE:WY) was reduced too.

Among 18 analysts covering Biogen (NASDAQ:BIIB), 8 have Buy rating, 0 Sell and 10 Hold. Therefore 44% are positive. Biogen had 37 analyst reports since December 19, 2018 according to SRatingsIntel. The stock of Biogen Inc. (NASDAQ:BIIB) has “Buy” rating given on Thursday, March 21 by Piper Jaffray. The stock of Biogen Inc. (NASDAQ:BIIB) has “Hold” rating given on Thursday, March 21 by Goldman Sachs. Mizuho maintained it with “Buy” rating and $416 target in Wednesday, March 20 report. The stock of Biogen Inc. (NASDAQ:BIIB) has “Buy” rating given on Thursday, March 21 by Cantor Fitzgerald. Canaccord Genuity downgraded Biogen Inc. (NASDAQ:BIIB) on Thursday, March 21 to “Hold” rating. The stock of Biogen Inc. (NASDAQ:BIIB) has “Buy” rating given on Monday, March 25 by H.C. Wainwright. As per Monday, March 4, the company rating was maintained by Cowen & Co. Cantor Fitzgerald maintained it with “Buy” rating and $400 target in Monday, March 4 report. The firm earned “Hold” rating on Thursday, March 21 by Stifel Nicolaus. As per Wednesday, December 19, the company rating was maintained by Morgan Stanley.

More notable recent Biogen Inc. (NASDAQ:BIIB) news were published by: Finance.Yahoo.com which released: “What Do Analysts Think About Biogen Inc.’s (NASDAQ:BIIB) Future? – Yahoo Finance” on May 02, 2019, also Seekingalpha.com with their article: “Biogen’s tofersen shows encouraging action in ALS study – Seeking Alpha” published on May 02, 2019, Nasdaq.com published: “Biogen (BIIB) Dips More Than Broader Markets: What You Should Know – Nasdaq” on April 09, 2019. More interesting news about Biogen Inc. (NASDAQ:BIIB) were released by: Nasdaq.com and their article: “Biogen Earnings: BIIB Stock Slips Despite Q1 Beat – Nasdaq” published on April 24, 2019 as well as Nasdaq.com‘s news article titled: “Biogen (BIIB) Beats on Q1 Earnings, Spinraza Drives Sales – Nasdaq” with publication date: April 24, 2019.

Investors sentiment decreased to 0.91 in Q4 2018. Its down 0.10, from 1.01 in 2018Q3. It dived, as 79 investors sold BIIB shares while 314 reduced holdings. 83 funds opened positions while 276 raised stakes. 181.17 million shares or 8.34% more from 167.21 million shares in 2018Q3 were reported. Peddock Capital Advsr Limited Com holds 2,048 shares or 0.37% of its portfolio. Plancorp Ltd Liability Corp invested in 2,901 shares or 0.4% of the stock. Ajo Ltd Partnership stated it has 0.01% in Biogen Inc. (NASDAQ:BIIB). Tirschwell And Loewy invested in 65,333 shares or 2.98% of the stock. Bancorp Of Hawaii invested in 0.04% or 1,354 shares. Wellington Management Gru Limited Liability Partnership owns 5.40 million shares or 0.41% of their US portfolio. 3,027 were reported by Wright Investors Service. Moreover, Nbt Savings Bank N A has 0.05% invested in Biogen Inc. (NASDAQ:BIIB). Moreover, Intact Invest Mngmt Incorporated has 0.01% invested in Biogen Inc. (NASDAQ:BIIB). West Oak Cap Ltd Llc holds 0% or 4,802 shares in its portfolio. State Of Tennessee Treasury Department stated it has 70,977 shares. 6,753 are owned by Triangle Wealth Mngmt. Teachers Retirement Systems Of The State Of Kentucky reported 106,279 shares stake. Welch & Forbes Llc reported 6,743 shares or 0.06% of all its holdings. Oak Assoc Limited Oh owns 23,918 shares.

Since January 30, 2019, it had 1 buy, and 0 selling transactions for $20.57 million activity. 62,800 shares were bought by DENNER ALEXANDER J, worth $20.57M on Wednesday, January 30.

Microsoft Corporation (NASDAQ:MSFT) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

Westend Advisors Lifted Its Stake in Biogen (BIIB) by $1.05 Billion; As Laredo Petroleum (LPI …

Westend Advisors Llc increased its stake in Biogen Inc. (BIIB) by 3.33% based on its latest 2018Q4 regulatory filing with the SEC. Westend Advisors …

Biogen Inc. (NASDAQ:BIIB) Logo

Westend Advisors Llc increased its stake in Biogen Inc. (BIIB) by 3.33% based on its latest 2018Q4 regulatory filing with the SEC. Westend Advisors Llc bought 3,493 shares as the company’s stock declined 1.50% while stock markets rallied. The institutional investor held 108,238 shares of the biological products (no diagnostic substances) company at the end of 2018Q4, valued at $32.57B, up from 104,745 at the end of the previous reported quarter. Westend Advisors Llc who had been investing in Biogen Inc. for a number of months, seems to be bullish on the $44.55 billion market cap company. The stock decreased 0.33% or $0.75 during the last trading session, reaching $229.78. About 302,695 shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 15.91% since April 29, 2018 and is uptrending. It has outperformed by 11.54% the S&P500. Some Historical BIIB News: 27/03/2018 – ICCR: Shareholders Will Vote on Resolutions at AbbVie, Amgen, Biogen, Bristol-Myers Squibb and Eli Lilly; 05/04/2018 – BIOGEN INC – UNDER TERMS OF AGREEMENT, BIOGEN AND SAMSUNG BIOEPIS WILL MAKE ROYALTY PAYMENTS TO ABBVIE; 24/04/2018 – Biotech Drug Production Pipeline Increasing Amid Buzz of Market Optimism; 10/04/2018 – AveXis sells on Novartis approach; 05/04/2018 – BIOGEN INC – BIOGEN EXPECTS TO LAUNCH IMRALDI IN EUROPE ON OCTOBER 16, 2018; 05/04/2018 – AbbVie in deal with Biogen to delay Humira biosimilar U.S. launch to 2023; 07/03/2018 – Europe’s medicines regulator calls for recall of Biogen, AbbVie multiple sclerosis drug; 24/04/2018 – Biogen Idec 1Q Rev $3.1B; 24/04/2018 – BIOGEN 1Q TECFIDERA REV. $986.9M, EST. $1.01B; 20/04/2018 – Biogen, Ionis Expect to Close Deal in 2Q

Key Group Holdings Cayman Ltd increased its stake in Laredo Petroleum Inc (LPI) by 99.29% based on its latest 2018Q4 regulatory filing with the SEC. Key Group Holdings Cayman Ltd bought 1.67M shares as the company’s stock declined 27.18% while stock markets rallied. The hedge fund held 3.35 million shares of the energy company at the end of 2018Q4, valued at $12.13 million, up from 1.68M at the end of the previous reported quarter. Key Group Holdings Cayman Ltd who had been investing in Laredo Petroleum Inc for a number of months, seems to be bullish on the $741.45M market cap company. The stock decreased 0.79% or $0.025 during the last trading session, reaching $3.155. About 759,672 shares traded. Laredo Petroleum, Inc. (NYSE:LPI) has declined 59.26% since April 29, 2018 and is downtrending. It has underperformed by 63.63% the S&P500. Some Historical LPI News: 26/04/2018 – LPI Capital Bhd 1Q Rev MYR381M; 12/03/2018 – LAREDO PETROLEUM COMMENTS IN SLIDESHOW; 03/04/2018 – Laredo Petroleum Non-Deal Roadshow Set By KLR Group for Apr. 10; 02/04/2018 – Laredo Petroleum Non-Deal Roadshow Set By KLR Group for Apr. 9; 02/05/2018 – LAREDO PETROLEUM 1Q ADJ EPS 24C, EST. 26C; 07/05/2018 – LAREDO PETROLEUM INC LPI.N : KLR GROUP RAISES TARGET PRICE BY $1 TO $12; 26/04/2018 – LPI Capital Bhd 1Q EPS MYR0.2184; 26/04/2018 – LPI CAPITAL 1Q REV. 381.0M RINGGIT; 26/04/2018 – LPI CAPITAL BHD – YEAR-AGO QTRLY REV 347.6 MLN RGT; YEAR-AGO QTRLY NET PROFIT 70.6 MLN RGT; 26/04/2018 – LPI CAPITAL 1Q NET INCOME 72.5M RINGGIT

Since January 30, 2019, it had 1 insider purchase, and 0 selling transactions for $20.57 million activity.

Investors sentiment decreased to 0.91 in Q4 2018. Its down 0.10, from 1.01 in 2018Q3. It turned negative, as 79 investors sold BIIB shares while 314 reduced holdings. 83 funds opened positions while 276 raised stakes. 181.17 million shares or 8.34% more from 167.21 million shares in 2018Q3 were reported. State Treasurer State Of Michigan accumulated 0.33% or 121,077 shares. Amundi Pioneer Asset Mgmt holds 0.14% in Biogen Inc. (NASDAQ:BIIB) or 492,612 shares. Ny State Teachers Retirement Systems reported 0.28% stake. Boston Advisors Ltd Company holds 1,091 shares. Paloma Ptnrs Mgmt Com reported 1,045 shares stake. Tirschwell And Loewy has 65,333 shares. Pictet Asset Management stated it has 0.47% in Biogen Inc. (NASDAQ:BIIB). Regentatlantic Capital owns 4,488 shares for 0.11% of their portfolio. Victory Cap Mngmt accumulated 52,060 shares. Rampart Ltd Co has invested 0.18% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Stearns Group, North Carolina-based fund reported 740 shares. First Retail Bank Of Omaha owns 0.49% invested in Biogen Inc. (NASDAQ:BIIB) for 3,000 shares. Rhenman & Ptnrs Asset Management has invested 2.06% in Biogen Inc. (NASDAQ:BIIB). Fosun Ltd reported 2,000 shares. Chicago Equity Ltd Com holds 13,584 shares.

Westend Advisors Llc, which manages about $932.40B US Long portfolio, decreased its stake in Jpmorgan Chase & Co. (NYSE:JPM) by 15,643 shares to 321,719 shares, valued at $31.41 billion in 2018Q4, according to the filing. It also reduced its holding in Starbucks Corp (NASDAQ:SBUX) by 126,125 shares in the quarter, leaving it with 532,487 shares, and cut its stake in Bristol (NYSE:BMY).

More notable recent Biogen Inc. (NASDAQ:BIIB) news were published by: 247Wallst.com which released: “Short Sellers Can’t Make Up Their Minds on Major Biotechs – 24/7 Wall St.” on April 26, 2019, also Benzinga.com with their article: “Earnings Scheduled For April 24, 2019 – Benzinga” published on April 24, 2019, Nasdaq.com published: “Will Biogen (BIIB) Beat Estimates Again in Its Next Earnings Report? – Nasdaq” on April 02, 2019. More interesting news about Biogen Inc. (NASDAQ:BIIB) were released by: Nasdaq.com and their article: “Biogen Announces Three New Nominees for Election to Board of Directors – Nasdaq” published on April 29, 2019 as well as Nasdaq.com‘s news article titled: “Why Nightstar Therapeutics Stock Skyrocketed 71% in March – Nasdaq” with publication date: April 03, 2019.

More notable recent Laredo Petroleum, Inc. (NYSE:LPI) news were published by: Benzinga.com which released: “Mid-Afternoon Market Update: Art’s-Way Manufacturing Drops After Q1 Results; Navidea Biopharmaceuticals Shares Climb – Benzinga” on April 08, 2019, also Benzinga.com with their article: “28 Stocks Moving In Tuesday’s Pre-Market Session – Benzinga” published on April 09, 2019, Globenewswire.com published: “Laredo Petroleum Announces Reduction of Personnel Costs by ~25% – GlobeNewswire” on April 08, 2019. More interesting news about Laredo Petroleum, Inc. (NYSE:LPI) were released by: Globenewswire.com and their article: “GATX Corporation Reports 2019 First-Quarter Results NYSE:GATX – GlobeNewswire” published on April 24, 2019 as well as Seekingalpha.com‘s news article titled: “Microcaps dominate midday movers – Seeking Alpha” with publication date: April 08, 2019.

Laredo Petroleum, Inc. (NYSE:LPI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

Bank Of Hawaii Has Trimmed Abbvie (ABBV) Stake by $372048; Nordea Investment Management …

Some Historical TSM News: 10/04/2018 – TSMC 2330.TW SAYS MARCH SALES +20.8 PCT ON YEAR; 27/03/2018 – Renesas to outsource vehicle …

Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) Logo

Nordea Investment Management Ab increased its stake in Taiwan Semiconductor Manufacturing Adr (TSM) by 36.64% based on its latest 2018Q4 regulatory filing with the SEC. Nordea Investment Management Ab bought 13,656 shares as the company’s stock rose 3.00% with the market. The institutional investor held 50,929 shares of the semiconductors company at the end of 2018Q4, valued at $1.88 million, up from 37,273 at the end of the previous reported quarter. Nordea Investment Management Ab who had been investing in Taiwan Semiconductor Manufacturing Adr for a number of months, seems to be bullish on the $214.87B market cap company. The stock decreased 1.21% or $0.54 during the last trading session, reaching $43.94. About 12.72M shares traded or 73.39% up from the average. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) has declined 8.36% since April 28, 2018 and is downtrending. It has underperformed by 12.73% the S&P500. Some Historical TSM News: 10/04/2018 – TSMC 2330.TW SAYS MARCH SALES +20.8 PCT ON YEAR; 27/03/2018 – Renesas to outsource vehicle microcontroller production to TSMC, sources say; 15/05/2018 – SAMSUNG ELEC 005930.KS IN TALKS WITH ZTE 0763.HK , OTHER SMARTPHONE MAKERS TO SUPPLY EXYNOS CHIPS – EXEC; 22/03/2018 – Australian Gov: US Patent Issued to TAIWAN SEMICONDUCTOR MANUFACTURING on March 20 for “Source and drain process for FinFET”; 19/04/2018 – TSMC 2330.TW TSM.N SAYS IT SEES SEMICONDUCTOR MARKET GROWTH AT 5 PCT; 02/05/2018 – Taiwan Semiconductor Manufacturing 1Q Net Profit NT$89.78B; 19/04/2018 – TSMC 2330.TW TSM.N SAYS SAYS FY REVENUE TO GROW 10 PCT VS EARLIER FORECAST OF 10-15 PCT DUE TO SOFTER SMARTPHONE DEMAND AND UNCERTAINTY IN CRYPTO CURRENCY MARKET; 08/03/2018 – TAIWAN’S TSMC 2330.TW TSM.N SAYS ORDERS MACHINERY EQUIPMENT WORTH T$506 MLN; 10/05/2018 – TSMC 2330.TW SAYS JAN-APR SALES +13.5 PCT ON YEAR TO T$329.95 BLN; 19/04/2018 – TSMC cuts 2018 sales target on weak iPhone demand

Bank Of Hawaii decreased its stake in Abbvie Inc (ABBV) by 3.75% based on its latest 2018Q4 regulatory filing with the SEC. Bank Of Hawaii sold 4,044 shares as the company’s stock declined 10.66% while stock markets rallied. The institutional investor held 103,704 shares of the major pharmaceuticals company at the end of 2018Q4, valued at $9.56 million, down from 107,748 at the end of the previous reported quarter. Bank Of Hawaii who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $117.81B market cap company. The stock increased 0.45% or $0.36 during the last trading session, reaching $79.7. About 5.46M shares traded. AbbVie Inc. (NYSE:ABBV) has declined 30.20% since April 28, 2018 and is downtrending. It has underperformed by 34.57% the S&P500. Some Historical ABBV News: 01/05/2018 – Merck Boosts Outlook as Keytruda Sales Surpass Diabetes Drugs; 05/04/2018 – AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Samsung Bioepis; 11/04/2018 – MYLAN NV – CO, FUJIFILM KYOWA KIRIN BIOLOGICS EXPECT TO RECEIVE DECISION FROM EMA REGARDING MAA FOR PROPOSED BIOSIMILAR TO HUMIRA IN H2 2018; 10/04/2018 – ABBVIE INC – FDA REQUIRES EXTENDED TIME FOR REVIEW OF ADDITIONAL INFORMATION IN NEW DRUG APPLICATION; 09/04/2018 – Merck’s Keytruda meets main goal in lung cancer trial; 10/04/2018 – Oncolytics Biotech: Combination Therapy With REOLYSIN(R), Keytruda(R) and/or anti-CD73 Immunotherapy Led to Rejection of Pre-Established Tumors; 16/04/2018 – NEARLY 70 PCT OF KEYTRUDA PLUS CHEMOTHERAPY PATIENTS ALIVE AFTER 1 YEAR VS 49 PCT FOR CHEMO ALONE – DATA; 05/04/2018 – Biogen, Samsung Bioepis to Make Royalty Payments to AbbVie; 23/05/2018 – MERCK & CO INC – KEYTRUDA HAS NOW DEMONSTRATED AN IMPROVED SURVIVAL BENEFIT IN ADVANCED NSCLC IN FIVE PHASE 3 TRIALS; 25/04/2018 – ABBVIE – IN SELECT-SUNRISE, UPADACITINIB MET PRIMARY ENDPOINT OF ACR20 ACROSS ALL DOSES AT WEEK 12

Investors sentiment increased to 0.83 in 2018 Q4. Its up 0.01, from 0.82 in 2018Q3. It improved, as 60 investors sold ABBV shares while 631 reduced holdings. 129 funds opened positions while 444 raised stakes. 996.27 million shares or 0.22% more from 994.12 million shares in 2018Q3 were reported. Mason Street Advsr Ltd Liability holds 212,072 shares. Iowa Bank & Trust reported 58,943 shares. Menlo Ltd holds 44,443 shares or 3.18% of its portfolio. Aviva Public Ltd Com has 0.44% invested in AbbVie Inc. (NYSE:ABBV). Mogy Joel R Investment Counsel reported 1.01% of its portfolio in AbbVie Inc. (NYSE:ABBV). Camelot Portfolios Ltd Com reported 0.2% stake. Arrowstreet Limited Partnership, a Massachusetts-based fund reported 7.14 million shares. Opus Capital Grp Ltd Limited Liability Company has 0.14% invested in AbbVie Inc. (NYSE:ABBV) for 7,404 shares. Groesbeck Investment Mngmt Corporation Nj accumulated 74,798 shares. California-based Lederer & Associate Investment Counsel Ca has invested 0.65% in AbbVie Inc. (NYSE:ABBV). Davis R M Inc reported 0.1% in AbbVie Inc. (NYSE:ABBV). Institute For Wealth Mngmt Ltd Com reported 13,715 shares. Sky Inv Group Llc invested 0.41% of its portfolio in AbbVie Inc. (NYSE:ABBV). Loomis Sayles And Limited Partnership holds 54,549 shares. Dock Street Asset Mngmt has 88,629 shares.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Fool.com which released: “Better Buy: Pfizer vs. AbbVie – Motley Fool” on April 28, 2019, also 247Wallst.com with their article: “Big Pharma Scares Off Short Sellers – 24/7 Wall St.” published on April 26, 2019, Seekingalpha.com published: “Trapping AbbVie – Seeking Alpha” on April 23, 2019. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Gurufocus.com and their article: “2 Large Drug Manufacturers Release 1st-Quarter Results – GuruFocus.com” published on April 26, 2019 as well as Fool.com‘s news article titled: “Why AbbVie Is in Better Shape Than You Might Think – The Motley Fool” with publication date: April 27, 2019.

Bank Of Hawaii, which manages about $1.30 billion and $1.16 billion US Long portfolio, upped its stake in Cbs Corporation (NYSE:CBS) by 9,267 shares to 13,899 shares, valued at $608,000 in 2018Q4, according to the filing. It also increased its holding in Vanguard (VB) by 2,451 shares in the quarter, for a total of 112,832 shares, and has risen its stake in Vanguard (VTV).

Since November 29, 2018, it had 0 buys, and 5 sales for $21.78 million activity. Schumacher Laura J also sold $8.81 million worth of AbbVie Inc. (NYSE:ABBV) on Tuesday, December 4. Shares for $3.82 million were sold by Gosebruch Henry O on Thursday, November 29. $5.40 million worth of AbbVie Inc. (NYSE:ABBV) was sold by CHASE WILLIAM J.

Nordea Investment Management Ab, which manages about $42.08 billion US Long portfolio, decreased its stake in Central Garden & Pet (NASDAQ:CENTA) by 41,600 shares to 110,500 shares, valued at $3.45 million in 2018Q4, according to the filing. It also reduced its holding in Toll Brothers (NYSE:TOL) by 62,738 shares in the quarter, leaving it with 36,000 shares, and cut its stake in Darling Ingredients (NYSE:DAR).

More notable recent Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) news were published by: Seekingalpha.com which released: “Report: TSMC won’t use full 7nm capacity in 1H19 – Seeking Alpha” on December 05, 2018, also Seekingalpha.com with their article: “Taiwan Semiconductor: Risky-Looking Chart But Undervalued Fundamentals – Seeking Alpha” published on December 11, 2018, Seekingalpha.com published: “Reviewing TSMC’s Q2 Results – Seeking Alpha” on July 24, 2018. More interesting news about Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) were released by: Seekingalpha.com and their article: “TSMC -2.6% on soft May revenue – Seeking Alpha” published on June 08, 2018 as well as Seekingalpha.com‘s news article titled: “Taiwan Semiconductor: 2019 Is A Buying Opportunity – Seeking Alpha” with publication date: January 21, 2019.

Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) Ratings Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

As Medicines Co (MDCO) Stock Price Rose, Shareholder Highvista Strategies Trimmed Position …

… Disease (SCD); 22/03/2018 – Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism …

The Medicines Company (NASDAQ:MDCO) Logo

Highvista Strategies Llc decreased its stake in Medicines Co (MDCO) by 12.64% based on its latest 2018Q4 regulatory filing with the SEC. Highvista Strategies Llc sold 33,900 shares as the company’s stock rose 20.76% with the market. The hedge fund held 234,340 shares of the major pharmaceuticals company at the end of 2018Q4, valued at $4.49M, down from 268,240 at the end of the previous reported quarter. Highvista Strategies Llc who had been investing in Medicines Co for a number of months, seems to be less bullish one the $2.08B market cap company. The stock decreased 0.21% or $0.06 during the last trading session, reaching $28.19. About 568,999 shares traded. The Medicines Company (NASDAQ:MDCO) has declined 22.18% since April 16, 2018 and is downtrending. It has underperformed by 26.55% the S&P500. Some Historical MDCO News: 03/04/2018 – Sancilio Pharmaceuticals Company Announces Altemia™ Receives Orphan Drug Designation from the European Medicines Agency for the Treatment of Pediatric Patients with Sickle Cell Disease (SCD); 22/03/2018 – Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism to Develop; 02/05/2018 – The Medicines Patent Pool Adds New Suppliers from South Africa and South Korea to its Growing Generic Manufacturing Network; 03/04/2018 – ASTRAZENECA PLC – CO AND MERCK ANNOUNCES EUROPEAN MEDICINES AGENCY HAS VALIDATED FOR REVIEW MARKETING AUTHORISATION APPLICATION FOR LYNPARZA (OLAPARIB); 08/03/2018 – REG-DURA VERMEER AND HEIJMANS IN BUILDING CONSORTIUM FOR EUROPEAN MEDICINES AGENCY NEW-BUILD PROJECT; 16/04/2018 – Melinta Therapeutics to Present Detailed Results from Vabomere TANGO II Trial as well as New In Vitro and In Vivo Findings from; 17/04/2018 – Biogen Builds on Its 40-Year Legacy in Neuroscience with Presentation of Research from Its Portfolio of Medicines and Investigational Programs for Neurodegenerative Diseases; 13/03/2018 – CSL CEO Paul Perreault Calls on Industry to Improve Patients’ Access to Medicines; 28/03/2018 – KINGWORLD MEDICINES GROUP LTD 1110.HK – BOARD RECOMMENDED DISTRIBUTION OF A FINAL DIVIDEND OF HK3.43 CENTS PER SHARE; 23/04/2018 – EUROPEAN MEDICINES AGENCY VALIDATES TYPE Il VARIATION FOR MERCK’S KEYTRUDA® (PEMBROLIZUMAB) IN COMBINATION WITH PEMETREXED (ALIMTA®) AND PLATINUM CHEMOTHERAPY AS FIRST-LINE THERAPY IN METASTATIC…

Coatue Management Llc increased its stake in Vera Bradley Inc (VRA) by 224.17% based on its latest 2018Q4 regulatory filing with the SEC. Coatue Management Llc bought 51,236 shares as the company’s stock declined 9.81% while stock markets rallied. The hedge fund held 74,092 shares of the consumer non-durables company at the end of 2018Q4, valued at $635,000, up from 22,856 at the end of the previous reported quarter. Coatue Management Llc who had been investing in Vera Bradley Inc for a number of months, seems to be bullish on the $402.46 million market cap company. The stock decreased 1.75% or $0.21 during the last trading session, reaching $11.78. About 201,599 shares traded. Vera Bradley, Inc. (NASDAQ:VRA) has declined 3.27% since April 16, 2018 and is downtrending. It has underperformed by 7.64% the S&P500. Some Historical VRA News: 14/03/2018 – VERA BRADLEY 4Q ADJ EPS 33C, EST. 32C; 02/04/2018 – Vera Bradley Presenting at Cowen Conference Tomorrow; 14/03/2018 Vera Bradley 4Q EPS 24c; 14/03/2018 – VERA BRADLEY SAYS COMP SALES CONTINUE TO BE NEGATIVELY IMPACTED BY Y-O-Y DECLINES IN STORE AND E-COMMERCE TRAFFIC; 14/03/2018 – Vera Bradley 4Q Rev $132M; 14/03/2018 – Vera Bradley Sees FY Rev $405M-$425M; 14/03/2018 – VERA BRADLEY INC VRA.O SEES FY 2019 SHR $0.35 TO $0.45; 16/03/2018 – Vera Bradley Closes Above 50-Day Moving Average: Technicals; 14/03/2018 – VERA BRADLEY INC VRA.O FY2019 SHR VIEW $0.47, REV VIEW $415.2 MLN — THOMSON REUTERS l/B/E/S; 14/03/2018 – VERA BRADLEY IN PACT WITH APPAREL PARTNERSHIP

Highvista Strategies Llc, which manages about $3.88 billion and $115.59M US Long portfolio, upped its stake in Vanguard Index Fds (VNQ) by 4,400 shares to 28,000 shares, valued at $2.09 million in 2018Q4, according to the filing.

Investors sentiment increased to 1.76 in 2018 Q4. Its up 0.68, from 1.08 in 2018Q3. It improved, as 23 investors sold MDCO shares while 36 reduced holdings. 38 funds opened positions while 66 raised stakes. 89.79 million shares or 2.48% more from 87.62 million shares in 2018Q3 were reported. Wolverine Asset Limited Liability Corp reported 3,513 shares. 61,377 were accumulated by Barclays Public Ltd Company. Amer International Grp Inc invested in 0% or 53,060 shares. Css Limited Liability Co Il holds 9,079 shares. Public Employees Retirement Association Of Colorado stated it has 0% of its portfolio in The Medicines Company (NASDAQ:MDCO). Comerica Bank invested in 103,304 shares. Greenlight Cap has invested 1.31% of its portfolio in The Medicines Company (NASDAQ:MDCO). Zurcher Kantonalbank (Zurich Cantonalbank) holds 0% or 4,372 shares. Tiaa Cref Mngmt Ltd owns 167,655 shares. Orbimed Limited Liability Corporation holds 0.02% or 54,600 shares. Charles Schwab Inv Mgmt Inc stated it has 363,711 shares or 0.01% of all its holdings. Louisiana State Employees Retirement invested in 0.03% or 24,716 shares. Millennium Limited Liability holds 0% or 136,106 shares. 335,000 were accumulated by Eventide Asset Mngmt Ltd. Prudential Financial holds 0% of its portfolio in The Medicines Company (NASDAQ:MDCO) for 107,052 shares.

Since November 16, 2018, it had 9 insider purchases, and 0 sales for $42.57 million activity. Cox Christopher T bought $2.01 million worth of stock. Another trade for 2,926 shares valued at $52,375 was bought by Timney Mark.

Analysts await The Medicines Company (NASDAQ:MDCO) to report earnings on April, 24. They expect $-0.35 EPS, up 56.25% or $0.45 from last year’s $-0.8 per share. After $-0.67 actual EPS reported by The Medicines Company for the previous quarter, Wall Street now forecasts -47.76% EPS growth.

More notable recent The Medicines Company (NASDAQ:MDCO) news were published by: Seekingalpha.com which released: “Medicines beats by $0.02 – Seeking Alpha” on February 27, 2019, also Livetradingnews.com with their article: “The Street’s Key Stock Analysts Research Reports – Live Trading News” published on March 29, 2019, Nasdaq.com published: “Monday 3/11 Insider Buying Report: MDCO, STBA – Nasdaq” on March 11, 2019. More interesting news about The Medicines Company (NASDAQ:MDCO) were released by: Streetinsider.com and their article: “Pre-Open Stock Movers 03/21: (GIII) (PTE) (CAG) Higher; (BIIB) (LQDA) (GES) Lower (more…) – StreetInsider.com” published on March 21, 2019 as well as 247Wallst.com‘s news article titled: “Top Analyst Upgrades and Downgrades: Bunge, Carbonite, FedEx, Kinder Morgan, Micron, Monster Beverage, Teva, Western Digital and More – 24/7 Wall St.” with publication date: March 28, 2019.

Investors sentiment decreased to 1.57 in 2018 Q4. Its down 1.25, from 2.82 in 2018Q3. It is negative, as 26 investors sold VRA shares while 27 reduced holdings. 20 funds opened positions while 63 raised stakes. 23.63 million shares or 0.66% less from 23.79 million shares in 2018Q3 were reported. The California-based Assetmark has invested 0% in Vera Bradley, Inc. (NASDAQ:VRA). Morgan Stanley invested 0% in Vera Bradley, Inc. (NASDAQ:VRA). Citadel Advisors Limited Liability reported 215,394 shares. California Pub Employees Retirement Systems invested in 0% or 93,611 shares. Mason Street Limited owns 6,698 shares. State Board Of Administration Of Florida Retirement Sys invested 0% of its portfolio in Vera Bradley, Inc. (NASDAQ:VRA). Raymond James And invested 0% in Vera Bradley, Inc. (NASDAQ:VRA). Deutsche Bank Ag has invested 0% in Vera Bradley, Inc. (NASDAQ:VRA). Thrivent Financial For Lutherans stated it has 0% in Vera Bradley, Inc. (NASDAQ:VRA). State Of Tennessee Treasury Department invested in 21,720 shares or 0% of the stock. Ameriprise Fincl Incorporated has 344,664 shares. Connecticut-based Tudor Invest Et Al has invested 0.02% in Vera Bradley, Inc. (NASDAQ:VRA). Shell Asset Comm has 0.02% invested in Vera Bradley, Inc. (NASDAQ:VRA). Stone Ridge Asset Mgmt Limited Liability Company owns 94,659 shares or 0.05% of their US portfolio. Bancorp Of Mellon Corp stated it has 0% in Vera Bradley, Inc. (NASDAQ:VRA).

Vera Bradley, Inc. (NASDAQ:VRA) Institutional Positions Chart

Related Posts:

  • No Related Posts